NEW YORK (GenomeWeb News) – Researchers at the University of Cardiff will have access to GeneGo's MetaCore software, as well as training and advanced support services, the company said today.
Under the agreement, the Welsh institution has become a GeneGo Center of Excellence, the company said, and will use the partnership to "provide a pathway analysis environment for all the university's researchers."
"We will be using MetaCore to support a range of researchers across Cardiff University who are using our transcriptomics core facility, including major programs in cancer research, infection and immunity, and neuropsychiatric disease," David Kipling, Cardiff's director of operations of central biotechnology services, said in a statement.
Financial terms of the agreement were not released.